結核と闘うために伝統的な医療と従来の治療を統合する:包括的なレビュー
Akriti Gaurav1, Zeeshan Fatima1, Ahmed Yaqinuddin2
1Amity Institute of Biotechnology, Amity University Haryana, Manesar, Gurugram-122413, India.
Current molecular medicine
|August 24, 2025
まとめ
アユルヴェーダ,シッダ,ウナニ を 含む インド の 伝統 医学 は,結核 (TB) の 治療 に 期待 を 抱い て い ます. これらの天然薬は 肝臓の損傷を軽減し 薬剤耐性に対抗し 従来の結核薬のより安全な代替品を提供することができます
科学分野:
- 統合医療
- 薬理学について
- 公衆衛生
背景:
- 結核は世界の健康問題であり,薬剤耐性や薬剤による肝毒性により悪化しています.
- 従来の抗結核治療は 長期にわたるスケジュールとより高い用量が必要で 毒性のリスクを高めます
- インドの国立結核対策プログラムは これらの課題に対応しています
研究 の 目的:
- 伝統的なインドの医療システムの有効性を従来の結核治療と比較する.
- 結核管理のためのアーユシュシステムからのハーブエキスの可能性を探求する.
- これらの代替治療の安全性と費用対効果を評価する.
主な方法:
- インドの伝統医学 (アーユルヴェーダ,シッダ,ウナニ) に関する科学文献のレビュー
- 肝毒性および薬剤耐性プロファイルを含む治療結果の比較
- 薬草による結核治療の安全性,費用,利用可能性の分析
主要な成果:
- アユルヴェーダ,シッダ,ウナニのハーブエキスは 抗結核の効能を示しています
- これらの伝統的な治療法は,結核薬に関連する肝毒性および肝損傷を軽減する可能性があります.
- 自然療法による結核治療は 抗生物質耐性との闘いにおいて有望であることが示されています
- アユシュによる治療は 一般的に安全で費用対効果があり 毒素を含まないものです
結論:
- 伝統的インド医学は TB の治療に有効な代替手段を提示しています
- 薬草は 副作用を軽減し 薬剤耐性を克服する可能性があります
- 科学的な検証により,AYUSHが認めている医療システムの結核対策の可能性が確認されています.
関連する概念動画
01:28Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
01:29Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
01:26Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
01:28Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
01:31Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
01:27Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K